From bad to worst !!!!!!!!

[Guest guest]

Hello everyone, I am an oriental medicine student. I recently

received a letter from Medscape. There was an update in the

vaccination schedule, now is worst !!!!!

Vaccines start at 0 months, with Hepatitis B, which of course still

contains mercury, and I do not seethe motive of this vaccination

taking in consideration that Hepatitis B is a sexually transmitted

disease, you canalso getit from sharing needles,ora bad

transfussion. And I do not think that any of our babies are going to

be doing any of these things as soon as they are born.

Also there are six vaccines at the age of 6 months... Isn't this

crazy??? When are these people going to learn !!!! I am not blamming

only to the vaccines, but I know they have a big role in the cause of

autism, specially when they are given at the wrong time (like when a

child is sick) and all together.

I also put the article with the updates so you cantake a look at it.

It sucks !!!!!!!!!!!!

Hepatitis B vaccine: At birth, give monovalent hepatitis B vaccine

to all newborns before hospital discharge. If the mother is positive

for hepatitis surface antigen (HBsAg), hepatitis B vaccine and 0.5 mL

of hepatitis B immune globulin should be given within 12 hours of

birth.

After the birth dose, the hepatitis B vaccine series should be

completed with either monovalent hepatitis B vaccine or a combination

vaccine containing hepatitis B vaccine, with the second dose given at

age 1 to 2 months and the final dose no earlier than age 24 weeks.

After completion of at least 3 doses of a licensed hepatitis B

vaccine series, at ages 9 to 18 months (typically at the next well-

child visit), infants born to mothers who are positive for HBsAg

should be tested for HBsAg and antibody to HBsAg. When combination

vaccines are given after the birth dose, 4 doses of hepatitis B

vaccine may be given. The 4-month dose is not needed if monovalent

hepatitis B vaccine is used for doses after the birth dose.

Rotavirus vaccine: The first dose should be given at ages 6 to 12

weeks, and the final dose in the series by age 32 weeks, because data

on safety and efficacy outside of these age ranges are insufficient.

Diphtheria and tetanus toxoids and acellular pertussis vaccine

(DTaP): Minimum age for administration is 6 weeks, and the fourth

dose may be given as early as age 12 months, but not sooner than 6

months since the third dose. The final dose in the series is given at

ages 4 to 6 years.

Haemophilus influenzae type b conjugate vaccine: Minimum age for

administration is 6 weeks. A dose at age 6 months is not needed if H

influenzae type b Neisseria meningitidis outer-membrane complex

protein conjugate (PedvaxHIB or ComVax; Merck) is given at ages 2 and

4 months. In children aged 12 months or older, DTaP/H influenzae type

b conjugate (TriHIBit; Sanofi Pasteur) combination products should

not be used for primary immunization but can be used as boosters

after any H influenzae type b conjugate vaccine.

Pneumococcal vaccine: Minimum age for administration is 6 weeks for

pneumococcal conjugate vaccine and 2 years for pneumococcal

polysaccharide vaccine. All healthy children aged 24 to 59 months

having any incomplete schedule should receive 1 dose of pneumococcal

conjugate vaccine. Children aged 2 years or older with underlying

medical conditions should receive pneumococcal polysaccharide

vaccine.

Influenza vaccine: Minimum age for administration is 6 months for

trivalent inactivated influenza vaccine and 2 years for live,

attenuated influenza vaccine. Children aged 6 to 59 months and all

close contacts of children ages 0 to 59 months should be vaccinated

every year, as should children aged 5 years or older with certain

risk factors, individuals in close contact with persons in groups at

higher risk, and any child whose parents request vaccination.

Either live, attenuated or trivalent inactivated influenza vaccine

may be administered to healthy, nonpregnant persons, ages 2 to 49

years, without underlying medical conditions that predispose them to

influenza complications. Children receiving trivalent inactivated

influenza vaccine should receive 0.25 mL if they are 6 to 35 months

old or 0.5 mL if they are 3 years or older.

Two doses, separated by 4 weeks or longer, should be given to

children younger than 9 years who are receiving influenza vaccine for

the first time or who were vaccinated for the first time last season,

but only received 1 dose.

Measles, mumps, and rubella vaccine: Minimum age for administration

is 12 months. The second dose of this vaccine should be given at ages

4 to 6 years, but it may be given sooner, provided 4 weeks or longer

have elapsed since the first dose and both doses are administered at

age 12 months or older.

Varicella vaccine: Minimum age for administration is 12 months. The

second dose should be given at ages 4 to 6 years, but it may be

administered 3 months or longer after the first dose. The second dose

should not be repeated if administered 28 days or more after the

first dose.

Hepatitis A vaccine: Hepatitis A vaccine is recommended for all

children aged 12 to 23 months, with 12 months being the minimum age

for administration. The 2 doses in the series should be given at

least 6 months apart. Children who are not fully vaccinated by age 2

years can be vaccinated at subsequent visits. Hepatitis A vaccine is

recommended for certain other groups of children, such as in areas

where vaccination programs target older children.

Meningococcal vaccine: Minimum age for administration is 2 years for

quadrivalent meningococcal conjugate vaccine and for quadrivalent

meningococcal polysaccharide vaccine. Although quadrivalent

meningococcal conjugate vaccine is recommended for high-risk groups

including children ages 2 to 10 years with terminal complement

deficiencies or anatomic or functional asplenia, the quadrivalent

meningococcal polysaccharide conjugate vaccine may also be used.

Individuals who received quadrivalent meningococcal polysaccharide

vaccine 3 years or more previously and who are still at increased

risk for meningococcal disease should be vaccinated with the

quadrivalent meningococcal conjugate vaccine